NuvaRing caused fatal clot | Nuvaring Lawsuit

The Record (Bergen County, NJ)

03-21-2008
Suit: NuvaRing caused fatal clot
THE ASSOCIATED PRESS
Date: 03-21-2008, Friday
Section: NEWS
Edtion: All Editions
TRENTON - The widower of a New Jersey woman who died suddenly while using the NuvaRing contraceptive is suing its maker, claiming it caused a deadly blood clot.

Robert Bozicev of Toms River claimed NuvaRing, which his wife, Jackie, 32, had been using for six months, contributed to her death. His lawsuit said she collapsed, had trouble breathing and died on the way to the hospital in December.

An autopsy showed a blood clot developed in a pelvic vein and lodged in her lungs. The family lawyer said she had no risk factors for such a complication and was in great health.

The couple have two young children.

The lawsuit seeks damages from Organon Pharmaceuticals and its new owner, Schering-Plough Corp. It was filed Wednesday in Essex County.

For the full article please click on the link below.

From: Suit: NuvaRing caused fatal clot by THE ASSOCIATED PRESS
Source: The Record (Bergen County, NJ), 3/21/2008.
Via: HighBeam™ Research

NuvaRing Class Action Lawsuit

Many people are wondering if there is a NuvaRing class action lawsuit against the birth control manufacturer Organon USA. Currently NuvaRing lawsuits are being filed by individuals and families throughout the United States. No NuvaRing class actions have been filed, however given the number of potential NuvaRing victims, attorneys and courts will likely look to multidistrict litigation and class actions to more efficiently handle the growing number of cases. The number of women reporting NuvaRing side effects such as blood clots and strokes is increasing.

NuvaRing was approved by the Food and Drug Administration in 2001 as the first hormonal vaginal contraceptive ring. Recently, more and more women have been coming forward suffering from serious side effects such as strokes and pulmonary embolisms. Individual lawsuits have been filed on behalf of women living throughout the United States.

NuvaRing Blood Clots & Stroke

NuvaRing side effects including blood clots, stroke and heart attack have been reported by women using this relatively new form of birth control. Side effects of NuvaRing are associated with the hormone desogestrel which can cause changes in the blood clotting system allowing blood clots to form more easily. NuvaRing birth control was approved by the Federal Drug Administration (FDA) on October 3, 2001 and first marketed in the United States in July 2002. Nuva Ring is used by approximately 1.5 million women worldwide.

NuvaRing is a flexible polyethylene vinyl acetate ring around 2 inches in diameter. Nuva Ring is considered a third generation combination hormonal contraceptive. It contains a combination of the hormones estrogen and etonogestrel which is a synthetic form of the progestin desogestrel. NuvaRing uses a different form of progestin compared to older contraceptives. Third generation contraceptives containing desogestrel have recently come under fire due to the increased risk of blood clots (venous thrombosis). The newer progestins (desogestrel) in third generation contraceptives were intended to lessen the adverse effects caused by older contraceptives such as hirsutism, weight gain, and acne.

Combination hormonal contraceptives contain both estrogen and progestins. NuvaRing contains the progestin desogestrel which, according to studies going back to 1995, doubles the risk of blood clots compared to second generation oral contraceptives. Organon, the manufacturer of NuvaRing is aware of the increased risk of blood clots associated with third generation oral contraceptives. The NuvaRing warning label states:

The hormones in NuvaRing® may cause changes in your blood clotting system  which may allow your blood to clot more easily. If blood clots form in your legs, they can travel to the lungs and cause a sudden blockage of a vessel carrying blood to the lungs. Rarely, clots occur in the blood vessels of the eye and may cause blindness, double vision, or other vision problems. The risk of getting blood clots may be greater with the type of progestin in   NuvaRing® than with some other progestins in certain low-dose birth control pills. It is unknown if the risk of blood clots is different with NuvaRing® use than with the use of certain birth control pills.

The side effects of Nuva Ring can increase depending on several risk factors. Increased risk factors include: women over age 35, smoking more than 15 cigarettes a day, diabetes, and high levels of blood cholesterol or fat. Warning signs of potentially more serious NuvaRing side effects include:

• sharp chest pain, coughing blood, or sudden shortness of breath (possible clot in the lung)
• pain in the calf (back of lower leg - possible clot in the leg)
• crushing chest pain or heaviness in the chest (possible heart attack)
• sudden severe headache or vomiting, dizziness, or fainting, problems with vision or speech, weakness, or numbness in an arm or leg (possible stroke)
• sudden partial or complete loss of vision (possible clot in the eye)

Currently there are no non-industry sponsored studies showing that third generation contraceptives such as NuvaRing are more effective when compared to second generation contraceptives especially given the increased risk of blood clots associated with desogestrel.